DNA methylation markers for sensitive detection of circulating tumor DNA in patients with gastroesophageal cancers
Background: Patients with gastric and gastroesophageal junction adenocarcinomas (G-GEJ ACs) face poor outcomes. Thus sensitive biomarkers for improved clinical management are highly warranted. Detection of circulating tumor DNA (ctDNA) using DNA methylation biomarkers is a highly sensitive approach...
Saved in:
| Main Authors: | N. Øgaard, C.R. Iden, S.Ø. Jensen, S.M. Mustafa, E. Aagaard, J.B. Bramsen, L.B. Ahlborn, J.P. Hasselby, K.S. Rohrberg, M.P. Achiam, C.L. Andersen, M. Mau-Sørensen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | ESMO Gastrointestinal Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949819824000657 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
by: Peiyi Liu, et al.
Published: (2024-11-01) -
Evaluating trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma who are ctDNA and HER2 positive: DECIPHER
by: E. Smyth, et al.
Published: (2024-12-01) -
Progression to cancer in patients with confirmed dysplasia compared to dysplasia downgraded to non-dysplastic metaplasia in Barrett’s esophagus: a retrospective cohort study in Sweden
by: Peter Elbe, et al.
Published: (2024-11-01) -
Therapy response monitoring in blood plasma from esophageal adenocarcinoma patients using cell-free DNA methylation profiling
by: Kathleen Schoofs, et al.
Published: (2024-12-01) -
Distinct microbiome dysbiosis and epigenetic anomaly in esophageal adenocarcinoma and its underlying Barrett’s esophagus
by: Takuya Shijimaya, et al.
Published: (2024-12-01)